Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Exosomes and Circulating Biomarkers Summit 2013

Gregory Scott's Biography



Gregory Scott, Patent Attorney, Klarquist Sparkman, LLP

Dr. Scott is a patent attorney at Klarquist Sparkman, LLP in Portland, Oregon, where he prepares and prosecutes U.S. and International patent applications, and advises clients about patent portfolio management, freedom-to-operate, and strategic product development. His technical experience includes applications related to biochemistry, molecular genetics, virology, immunology, and neurobiology. Dr. Scott’s practice emphasis is in biotechnology, including applications relating to biologic drugs and their use, and diagnostic methods involving exosome and DNA expression profiling.

Gregory Scott Image

Biomarker IP after Prometheus: Patenting the Unpatentable

Friday, 13 September 2013 at 16:45

Add to Calendar ▼2013-09-13 16:45:002013-09-13 17:45:00Europe/LondonBiomarker IP after Prometheus: Patenting the UnpatentableExosomes and Circulating Biomarkers Summit 2013 in San Diego, CASan Diego, CASELECTBIOenquiries@selectbiosciences.com

In this tag-team presentation, two IP lawyers will discuss the latest trends in this evolving field:

The Supreme Court decision in Mayo Collaborative Services v. Prometheus Laboratories, Inc. shifted the biomarker IP landscape by raising the bar to obtain meaningful patent protection for diagnostic methods involving biomarker detection.  We will review recent developments in patent law concerning diagnostic method claims, and the approaches we are currently using to successfully address the Prometheus standard.


Add to Calendar ▼2013-09-12 00:00:002013-09-13 00:00:00Europe/LondonExosomes and Circulating Biomarkers Summit 2013Exosomes and Circulating Biomarkers Summit 2013 in San Diego, CASan Diego, CASELECTBIOenquiries@selectbiosciences.com